Krsnaa Diagnostics Intrinsic Value
KRSNAA • Healthcare Services
Current Stock Price
₹599.10
Primary Intrinsic Value
₹354.24
Market Cap
₹958.6 Cr
-29.9%
Downside
Median Value
₹420.00
Value Range
₹189 - ₹945
Assessment
Trading Above Calculated Value
Safety Margin
-42.6%
KRSNAA Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹354.24 | ₹283.39 - ₹425.09 | -40.9% | EPS: ₹29.52, Sector P/E: 12x |
| Book Value Method | asset | ₹551.88 | ₹496.69 - ₹607.07 | -7.9% | Book Value/Share: ₹551.88, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹420.00 | ₹378.00 - ₹462.00 | -29.9% | Revenue/Share: ₹525.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹945.00 | ₹850.50 - ₹1039.50 | +57.7% | EBITDA: ₹252.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹239.64 | ₹191.71 - ₹287.57 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹188.93 | ₹170.04 - ₹207.82 | -68.5% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹243.24 | ₹218.92 - ₹267.56 | -59.4% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹720.00 | ₹648.00 - ₹792.00 | +20.2% | ROE: 10.9%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹605.44 | ₹544.90 - ₹665.98 | +1.1% | EPS: ₹29.52, BVPS: ₹551.88 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
KRSNAA Intrinsic Value Analysis
What is the intrinsic value of KRSNAA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Krsnaa Diagnostics (KRSNAA) is ₹420.00 (median value). With the current market price of ₹599.10, this represents a -29.9% variance from our estimated fair value.
The valuation range spans from ₹188.93 to ₹945.00, indicating ₹188.93 - ₹945.00.
Is KRSNAA undervalued or overvalued?
Based on our multi-method analysis, Krsnaa Diagnostics (KRSNAA) appears to be trading above calculated value by approximately 29.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.46 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 10.9% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 29.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.66x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Krsnaa Diagnostics
Additional stock information and data for KRSNAA
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2024 | ₹24 Cr | ₹-41 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹76 Cr | ₹22 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹128 Cr | ₹8 Cr | Positive Free Cash Flow | 7/10 |
| March 2017 | ₹64 Cr | ₹37 Cr | Positive Free Cash Flow | 8/10 |
| March 2016 | ₹-23 Cr | ₹-47 Cr | Negative Cash Flow | 3/10 |